Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil for Pulmonary Hypertension in Sickle Cell Disease
2007-000446-12Phase 2Terminated
- Sponsor
- Imperial College London
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in pulmonary hypertension (PH) and sickle cell disease (SCD) comparing Sildenafil with Placebo (2 arms). Primary endpoint: Six-minute walk distance improvement. Started Mar 2008; status: terminated.
02
Drugs
sildenafil
03
Conditions
pulmonary hypertension (PH)sickle cell disease (SCD)
Beyond the preview
Go deeper on 2007-000446-12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000446-12.